Amanta Healthcare Reports Fund Utilization Deviation and Q2 FY2026 Financial Results

Amanta Healthcare Limited (ISIN: INE084K01015) has reported a deviation in fund utilization for its Initial Public Offering (IPO) proceeds and released its financial results for the quarter ended September 30, 2025. The company, which raised Rs 126 crore through its IPO, has made adjustments to its fund allocation due to GST payment modifications.

Fund Utilization Deviation

The company disclosed that the deviation occurred due to changes in GST payments over the costs mentioned in the IPO Offer Document. This resulted in adjustments to issue expenses and a corresponding reduction in general corporate purpose expenses. The revised fund allocation is as follows:

Purpose	Original Allocation (Rs. in lakhs)	Revised Allocation (Rs. in lakhs)	Amount Utilized (Rs. in lakhs)	Amount Unutilized (Rs. in lakhs)
SteriPort manufacturing line at Hariyala, Kheda, Gujarat	7,000.00	7,000.00	764.81	6,235.19
SVP manufacturing line at Hariyala, Kheda, Gujarat	3,013.11	3,013.11	-	3,013.11
General corporate purposes	660.46	302.08	-	302.08
Issue Expenses	1,926.43	2,284.81	2,265.21	19.60
Total	12,600.00	12,600.00	3,030.02	9,569.98

The Audit Committee reviewed the statement and provided no comments on the deviation.

Q2 FY2026 Financial Highlights

Amanta Healthcare also released its unaudited financial results for the quarter and six months ended September 30, 2025:

Revenue from operations for Q2 FY2026 stood at Rs. 7,088.73 lakhs, compared to Rs. 6,673.12 lakhs in Q2 FY2025.
Profit before tax for Q2 FY2026 was Rs. 227.78 lakhs, down from Rs. 316.66 lakhs in the same quarter last year.
Net profit for Q2 FY2026 decreased to Rs. 120.75 lakhs from Rs. 225.70 lakhs in Q2 FY2025.

Half-Year Performance

For the six months ended September 30, 2025:

Revenue from operations reached Rs. 13,619.44 lakhs, up from Rs. 13,483.07 lakhs in the corresponding period of the previous year.
Profit before tax was Rs. 720.43 lakhs, compared to Rs. 266.24 lakhs in the same period last year.
Net profit increased to Rs. 471.47 lakhs from Rs. 189.50 lakhs in the previous year's corresponding period.

Balance Sheet Highlights

As of September 30, 2025:

Total assets stood at Rs. 48,831.55 lakhs, up from Rs. 38,175.85 lakhs as of March 31, 2025.
Total equity increased to Rs. 21,068.01 lakhs from Rs. 9,638.83 lakhs at the end of the previous fiscal year.
Cash and cash equivalents significantly improved to Rs. 9,196.41 lakhs from Rs. 22.06 lakhs as of March 31, 2025.

The company's financial position shows growth in assets and equity, with a substantial improvement in cash reserves. However, the quarterly profit has seen a decline compared to the same period last year. The fund utilization deviation reflects the company's adaptation to GST-related changes, with a focus on optimizing its manufacturing capabilities and managing issue expenses efficiently.

Amanta Healthcare continues to progress with its expansion plans, particularly in setting up new manufacturing lines for SteriPort and SVP products at its Hariyala facility in Kheda, Gujarat. The company's strategic allocation of IPO funds demonstrates its commitment to enhancing production capabilities while managing financial resources prudently.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.91%	-5.17%	-10.83%	-21.83%	-21.83%	-21.83%

Amanta Healthcare Limited , a pharmaceutical manufacturing and contract manufacturing services company, has reported its financial results for the quarter ended September 30, 2025, along with the successful completion of its Initial Public Offering (IPO).

Financial Performance

For the quarter ended September 30, 2025, Amanta Healthcare reported:

Particulars	Q2 FY2026 (Rs. in lakhs)
Total Income	7,095.80
Net Profit	207.80

For the half-year ended September 30, 2025, the company's performance was as follows:

Particulars	H1 FY2026 (Rs. in lakhs)
Total Income	13,850.45
Net Profit	185.50

IPO Completion and Listing

Amanta Healthcare successfully completed its Initial Public Offering during the quarter. Key details of the IPO include:

Number of equity shares issued: 10,000,000
Issue price: Rs. 126 per share
Total funds raised: Rs. 12,600 lakhs
Listing date: September 9, 2025
Listed on: BSE Limited and National Stock Exchange of India Limited

The company recognized IPO-related expenses of Rs. 262.88 lakhs as an exceptional item in its financial statements.

Utilization of IPO Proceeds

The company has outlined the following utilization plan for the IPO proceeds:

Purpose	Amount Allocated (Rs. in lakhs)	Amount Utilized (Rs. in lakhs)	Amount Unutilized (Rs. in lakhs)
New manufacturing line for SteriPort	7,000.00	764.81	6,235.19
New manufacturing line for SVP	3,013.11	-	3,013.11
General corporate purposes	302.08	302.08	-
Issue Expenses	2,284.81	2,265.21	19.60
Total	12,600.00	3,030.02	9,569.98

Auditor's Review

PriceWaterhouseCoopers provided an unmodified review opinion on the financial results for the quarter and half-year ended September 30, 2025.

Amanta Healthcare's successful IPO and listing mark a significant milestone for the company, providing it with capital for potential expansion and growth in the pharmaceutical manufacturing sector.